Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Nannelli

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hematology/Oncology Clinics of North America|April 5, 2016
Glucose-6-Phosphate Dehydrogenase DeficiencyLucio Luzzatto, Caterina Nannelli, Rosario Notaro
American Journal of Human Genetics|November 3, 2023
Potentially pathogenic and pathogenic G6PD variantsLucio Luzzatto, Caterina Nannelli, Rosario Notaro
British Journal of Haematology|July 7, 2023
Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classificationCaterina Nannelli, Andrea Bosman, Jane Cunningham, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2008
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancerFrancesca Malentacchi, Lisa Simi, Caterina Nannelli, et al.
American Journal of Hematology|October 12, 2024
Massive hemolysis in paroxysmal nocturnal hemoglobinuria after switching from proximal complement inhibitor to anti-C5 therapy: A lesson not to be forgottenAntonio M Risitano, Camilla Frieri, Luana Marano, et al.
Blood|August 27, 2020
Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNHMichela Sica, Annamaria Pellecchia, Maria De Angioletti, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2025
ETV4 and ETV1-mediated downregulation of the secretory leukocyte protease inhibitor contributes to the indolent phenotype of early-stage prostate cancerIrene Cosi, Annalisa Moccia, Caterina Nannelli, et al.
British Journal of Haematology|January 20, 2023
The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumabMichela Sica, Federica Barone, Caterina Nannelli, et al.
Bulletin of the World Health Organization|July 29, 2024
New WHO classification of genetic variants causing G6PD deficiencyLucio Luzzatto, Germana Bancone, Pierre-Antoine Dugué, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|April 5, 2016
Glucose-6-Phosphate Dehydrogenase DeficiencyLucio Luzzatto, Caterina Nannelli, Rosario Notaro
American Journal of Human Genetics|November 3, 2023
Potentially pathogenic and pathogenic G6PD variantsLucio Luzzatto, Caterina Nannelli, Rosario Notaro
British Journal of Haematology|July 7, 2023
Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classificationCaterina Nannelli, Andrea Bosman, Jane Cunningham, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2008
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancerFrancesca Malentacchi, Lisa Simi, Caterina Nannelli, et al.
American Journal of Hematology|October 12, 2024
Massive hemolysis in paroxysmal nocturnal hemoglobinuria after switching from proximal complement inhibitor to anti-C5 therapy: A lesson not to be forgottenAntonio M Risitano, Camilla Frieri, Luana Marano, et al.
Blood|August 27, 2020
Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNHMichela Sica, Annamaria Pellecchia, Maria De Angioletti, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2025
ETV4 and ETV1-mediated downregulation of the secretory leukocyte protease inhibitor contributes to the indolent phenotype of early-stage prostate cancerIrene Cosi, Annalisa Moccia, Caterina Nannelli, et al.
British Journal of Haematology|January 20, 2023
The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumabMichela Sica, Federica Barone, Caterina Nannelli, et al.
Bulletin of the World Health Organization|July 29, 2024
New WHO classification of genetic variants causing G6PD deficiencyLucio Luzzatto, Germana Bancone, Pierre-Antoine Dugué, et al.
Pageof 1